Page 257 - Read Online

D'Angelo et al. J Cancer Metastasis Treat 2019;5:30 I http://dx.doi.org/10.20517/2394-4722.2018.86 Page 17 of 18

48. Yim K, Ro SM, Lee J. Breast cancer metastasizing to the stomach mimicking primary gastric cancer: a case report. World J Gastroenterol
2017;23:2251-7.
49. Ushida Y, Yoshimizu S, Horiuchi Y, Yoshio T, Ishiyama A, et al. Clinicopathological features of metastatic gastric tumors originating from
breast cancer: analysis of eleven cases. World J Oncol 2018;9:104-9.
50. Xu L, Liang S, Yan N, Zhang L, Gu H, et al. Metastatic gastric cancer from breast carcinoma: a report of 78 cases. Oncol Lett
2017;14:4069-77.
51. Waseda Y, Hayashi T, Kaneko S. Gastric metastasis from breast cancer visualized by magnifying endoscopy with narrow-band imaging.
Dig Endosc 2015;27:708-15.
52. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative bresat disease. N Engl J Med 1985;312:146-51.
53. McLemore EC, Pockaj BA, Reynolds C, Gray RJ, Hernandez JL, et al. Breast cancer: presentation and intervention in women with
gastrointestinal metastasis and carcinomatosis. Ann Surg Oncol 2005;12:886-94.
54. Simchuk EJ, Low DE. Direct oesphageal metastasis from a distant primary tumour is a submucosal process: a review of six cases. Dis
Esophagus 2001;14:247-50.
55. Caramella E, Bruneton JN, Roux P, Aubanel D, Lecomte P. Metastases of the digestive tract: report of 77 cases and review of the
literature. Eur J Radiol 1983;3:331-8.
56. Varanasi RV, Saltzman JR, Krims P, Crimaldi A, Colby J. Breast carcinoma metastatic to the oesophagus: clinicopathological and
management features of four cases and literature review. Am J Gastroenterol 1995;90:1495-9.
57. Tohfe M, Shami P, Aftimos G, Saade M. Gastrointestinal metastases from breast cancer; a case report. South Med J 2003;96:624-5.
58. Zabel BA, Wang Y, Lewén S, Berahovich RD, Penfold ME, et al. Elucidation of CXCR7-mediated signaling events and inhibition of
CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J Immunol 2009;183:3204-11.
59. Andre F, Xia W, Conforti R, Wei Y, Boulet T, et al. CXCR4 expression in early breast cancer and risk of distant recurrence. Oncologist
2009; 14:1182-8.
60. Bartolomé RA, Ferreiro S, Miquilena-Colina ME, Martínez-Prats L, Soto-Montenegro ML, et al. The chemokine receptor CXCR4 and
the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs. Am J Pathol 2009;174:602-12.
61. Kryczek I, Wei S, Keller E, Liu R, Zou W. Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell
Physiol 2007;292:C987-95.
62. Borst MJ, Ingold JA. Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery 1993;114:637-41;
discussion 641-2.
63. Hunter KW, Crawford NP, Alsarraj J. Mechanisms of metastasis. Breast Cancer Res 2008;10:S2.
64. Wendt MK, Taylor MA, Schiemann BJ, Schiemann WP. Down-regulation of epithelial cadherin is required to initiate metastatic
outgrowth of breast cancer. Mol Biol Cell 2011;22:2423-35.
65. Yu HA, Kim EY, Seo MJ, Chung E, Cho MJ, et al. Stomach and colon metastasis from breast cancer. Ewha Med J 2014;37:98-104.
66. Koike K, Kitahara K, Higaki M, Urata M, Yamazaki F, et al. Clinicopathological features of gastric metastasis from breast cancer in three
cases. Breast Cancer 2014;21:629-34.
67. Signorelli C, Pomponi-Formiconi D, Nelli F, Pollera CF. Single colon metastasis from breast cancer: a clinical case report. Tumori
2005;91:424-27.
68. Taal BG, Boot H, van Heerde P, de Jong D, Hart AA, et al. Primary non-hodgkin lymphoma of the stomach: endoscopic pattern and
prognosis in low versus high grade malignancyin relation to the MALT concept. Gut 1996;39:556-61.
69. Marshall, ME. Gastrointestinal metastases from carcinoma of the breast. J Ky Med Assoc 1983;81:154-7.
70. Qu Q, Zong Y, Fei XC, Chen XS, Xu C, et al. The importance of biopsy in clinically diagnosed metastatic lesions in patients with breast
cancer. World J Surg Oncol 2014;12:93.
71. Shimada H, Okazumi S, Koyama M, Murakami K. Japanese gastric cancer association task force for research promotion: clinical utility
of f-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature. Gastric Cancer
18
2011;14:13-21.
72. Chu PG, Weiss LM. Immunoistochemical characterization of signet-ring cell carcinomas of the stomach, breast and colon. Am J Clin
Pathol 2004;121:884-92.
73. López Deogracias M, Flores Jaime L, Arias-Camisón I, Zamacola I, Murillo Guibert J, et al. Rectal metastasis from lobular breast
carcinoma 15 years after primary diagnosis. Clin Trasl Oncol 2010;12:150-3.
74. Matsui M, Kojima O, Kawakami S, Uehara Y, Takahashi T. The prognosis of patients with gastric cancer possessing sex hormone
receptors. Surg Today 1992;22:421-5.
75. Curtit E, Nerich V, Mansi L, Chaigneau L, Cals L, et al. Discordances in estrogen receptor status, progesterone receptor status, and HER-
2 status between primary breast cancer adn metastastis. Oncologist 2013;18:667-74.
76. Tot T. The role of cytokeratins 20 and 7 and estrogen receptor analysis in separation of metastatic lobular carcinoma of the breast and
metastatic signet ring cell carcinoma of the gastrointestinal tract. APMIS 2000;108:467-72.
77. Werling RW, Yaziji H, Bacchi CE, Gown AM. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an
immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol 2003;27:303-10.
78. Saad RS, Ghorab Z, Khalifa MA, Xu M. CDX2 as a marker for intestinal differentation: its utility and limitations. World J Gastrointest
Surg 2011;3:159-66.
79. Bhargava R, Beriwal S, Dabbs DJ. Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity.
Am J Clin Pathol 2007;127:103-13.
80. Wang Z, Spaulding B, Sienko A, Liang Y, Li H, et al. Mammaglobin, a valuable diagnostic marker for metastatic breast carcinoma. Int J
Clin Exp Pathol 2009;2:384-9.
81. Gown AM, Fulton RS, Kandalaft PL. Markers of metastatic carcinoma of breast origin. Histopathology 2016;68:86-95.